CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • CSL (ASX: CSL)
    Latest News

    Young man with a laptop in hand watching stocks and trends on a digital chart.
    Broker Notes

    Buy, hold, sell: Sigma Healthcare, CSL, and Lynas shares

    Analysts have given their verdict on these shares.

    Read more »

    Ordinary Australians waiting at the bus stop using their phones to trade ASX 200 shares today
    Share Market News

    Top 10 most-traded ASX shares last week

    These shares saw the most trading activity during the week.

    Read more »

    A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
    Cheap Shares

    Is the 2025 ASX share selloff your chance to buy generational bargains?

    These shares don't often trade at such a discount.

    Read more »

    A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
    Share Market News

    These ASX 200 blue chip shares could rise 25% to 40%

    Analysts are bullish on these big names. Let's see what they are recommending.

    Read more »

    A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
    Broker Notes

    3 of the best Australian stocks to buy after the market selloff

    Analysts think these shares could rise strongly from where they trade today.

    Read more »

    Three scientists wearing white coats and blue gloves dance together in a lab.
    Healthcare Shares

    CSL shares outperforming today on $2.3 billion US news

    CSL shares are grabbing ASX investor interest on Wednesday. Here’s why.

    Read more »

    ASX 200 bank share trading depicted by red buy and sell dice tumbling across a sheet of data in colourful graphics
    Share Market News

    These were the 10 most-traded Australian shares last week

    These ASX stocks were in focus last week.

    Read more »

    Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
    Healthcare Shares

    Are CSL shares a buy after their heavy decline?

    Let's see what one broker is saying about the biotech giant.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    How to invest

    ASX sell-off accelerates: Is it time to sell shares?

    It might be tempting to hit the sell button on days like today...

    Read more »

    A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
    Healthcare Shares

    CSL, Sonic, and Sigma Healthcare shares: Buy, hold, or sell?

    Analysts share their ratings and opinions on 3 large-cap ASX 200 healthcare stocks.

    Read more »

    a close up of a man with wide open eyes and wide open mouth holding his head and reacting in shock and surprise to some share market ews.
    How to invest

    How to prepare for a share market crash… before it's too late

    The ASX 200 Index is now down more than 3% from its October peak.

    Read more »

    young female doctor with digital tablet looking confused.
    Healthcare Shares

    Down 38% in a year, are CSL shares now a buy?

    A leading investment expert delivers his verdict on CSL shares.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note